ANAB
AnaptysBio Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$64.81
+1.02 ▲ +1.60%
🌙 3월 13일 5:25 PM ET (한국 3/14 06:25)
$64.81
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -0.52 | Insider Own | 6.87% | Shs Outstand | 0.03B | Perf Week | 16.96% |
| Market Cap | 1.86B | Forward P/E | - | EPS next Y | 3.08% | Insider Trans | -7.69% | Shs Float | 0.03B | Perf Month | 17.3% |
| Enterprise Value | 1.84B | PEG | - | EPS next Q | -0.96 | Inst Own | 99.1% | Short Float | 20.05% | Perf Quarter | 44.18% |
| Income | -0.01B | P/S | 7.94 | EPS this Y | -755.5% | Inst Trans | -5.64% | Short Ratio | 11.06 | Perf Half Y | 179.35% |
| Sales | 0.23B | P/B | 48.8 | EPS next 5Y | 10.99% | ROA | -3.12% | Short Interest | 5.37M | Perf YTD | 33.68% |
| Book/sh | 1.33 | P/C | 5.98 | EPS past 3/5Y | 53.48% 8.82% | ROE | -24.49% | 52W High | -2.78% ($66.66) | Perf Year | 284.86% |
| Cash/sh | 10.84 | P/FCF | 95.01 | Sales past 3/5Y | 183.58% 25.62% | ROIC | -4.06% | 52W Low | 323.04% ($15.32) | Perf 3Y | 187.15% |
| Dividend Est. | - | EV/EBITDA | 36.61 | EPS Y/Y TTM | 94.31% | Gross Margin | 98.97% | Volatility(W/M) | 6.55% 6.82% | Perf 5Y | 203.56% |
| Dividend TTM | - | EV/Sales | 7.85 | Sales Y/Y TTM | 157.01% | Oper. Margin | 20.42% | ATR (14) | 3.91 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 9.07 | EPS Q/Q | 321.26% | Profit Margin | -5.64% | RSI (14) | 67.5 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 9.07 | Sales Q/Q | 151.08% | SMA20 | 13.38% ($57.16) | Beta | 0.36 | Target Price | $77.45 |
| Payout | - | Debt/Eq | 7.81 | Earnings | 3000000 | SMA50 | 25.49% ($51.65) | Rel Volume | 1.63 | Prev Close | $63.79 |
| Employees | 104 | LT Debt/Eq | 7.75 | EPS/Sales Surpr. | 83.12% 24.37% | SMA200 | 84.55% ($35.12) | Avg Volume(3M) | 0.49M | Price | $64.81 |
| IPO | 2017/1/26 | Option/Short | Yes/Yes | Trades | 8667 | Volume | 790,202 | Change | 1.6% |
뉴스 로딩 중...